78-LB: Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared With Insulin Degludec in Patients With Type 2 Diabetes (SURPASS-3)
Doctors primarily prescribe it for conditions like high blood pressure, fluid retention (edema) caused by heart or liver disease, and hormonal conditions
This includes adopting a balanced diet, increasing physical activity, and maintaining regular medical follow-ups
For example, studies on semaglutide 2.4 mg daily reveal an average 8% weight loss in individuals with diabetes over 60 weeks, while those without diabetes see closer to 11%
https:/doi.org/10.1038/s41433-020-0820-5 36
This herb has been traditionally used in menorrhagia and female reproductive dysfunctions